We are live on
!
Find out more
CEI
Clark Estates Inc Portfolio holdings
AUM
$434M
1-Year Est. Return
15%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+15%
3 Year Est. Return
+34.46%
5 Year Est. Return
+32.78%
10 Year Est. Return
+216.75%
AUM
$434M
AUM Growth
+$17.5M
(+4.2%)
Cap. Flow
-$3.16M
Cap. Flow
% of AUM
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
52.76%
Holding
108
New
11
Increased
17
Reduced
16
Closed
18
Avg Time Held
10.2
quarters
Top 10 Avg Time Held
4.1
quarters
Top 20 Avg Time Held
5.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$25.8M |
| 2 |
Henry Schein
HSIC
|
+$9.71M |
| 3 |
Unilever
UL
|
+$3.76M |
| 4 |
Best Buy
BBY
|
+$2.9M |
| 5 |
Sony
SONY
|
+$2.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Euclidean Fundamental Value ETF
ECML
|
+$15M |
| 2 |
Avanos Medical
AVNS
|
+$11.8M |
| 3 |
IQVIA
IQV
|
+$7.5M |
| 4 |
Solventum
SOLV
|
+$6.56M |
| 5 |
Medtronic
MDT
|
+$5.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.82% |
| 2 | Miscellaneous | 21.8% |
| 3 | Technology | 13.51% |
| 4 | Communication Services | 11.78% |
| 5 | Consumer Staples | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Johnson & Johnson
JNJ
$599B
| $1.04M | 0.24% |
4,105
| – | – |
2013 Q2
52 quarters
|
|
77
Apple
AAPL
$4.98T
| $900K | 0.21% |
3,111
| – | – |
2023 Q2
12 quarters
|
|
78
IBM
IBM
$217B
| $859K | 0.2% |
3,055
| – | – |
2013 Q2
52 quarters
|
|
79
Procter & Gamble
PG
$355B
| $843K | 0.19% |
5,750
| – | – |
2013 Q2
52 quarters
|
|
80
DXC Technology
DXC
$2.04B
| $816K | 0.19% |
92,200
-37,800
| -29% | -$392K |
2023 Q4
10 quarters
|
|
81
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $787K | 0.18% |
1,054
| – | – |
2023 Q1
13 quarters
|
|
82
Amazon
AMZN
$2.79T
| $582K | 0.13% |
2,440
| – | – |
2023 Q2
12 quarters
|
|
83
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
| $409K | 0.09% |
1,350
| – | – |
2023 Q2
12 quarters
|
|
84
Alphabet (Google) Class A
GOOGL
$4.33T
| $393K | 0.09% |
1,100
| – | – |
2018 Q1
33 quarters
|
|
85
Microsoft
MSFT
$4.04T
| $318K | 0.07% |
853
| – | – |
2023 Q2
12 quarters
|
|
86
ExxonMobil
XOM
$716B
| $304K | 0.07% |
2,224
| – | – |
2023 Q2
12 quarters
|
|
87
Chubb
CB
$134B
| $273K | 0.06% |
800
| – | – |
2024 Q1
9 quarters
|
|
88
iShares MSCI EAFE ETF
EFA
$76.8B
| $246K | 0.06% |
2,370
| – | – |
2025 Q2
4 quarters
|
|
89
JPMorgan Chase
JPM
$881B
| $245K | 0.06% |
750
| – | – |
2025 Q2
4 quarters
|
|
90
PepsiCo
PEP
$173B
| $223K | 0.05% |
1,650
| – | – |
2025 Q4
2 quarters
|
|
91
Allison Transmission
ALSN
$9.22B
| – | – |
-17,750
| Closed | -$2.08M | – |
|
92
Everforth Inc
EFOR
$1.57B
| – | – |
-48,800
| Closed | -$1.89M | – |
|
|
93
DELISTED
Avanos Medical
AVNS
| – | – |
-845,000
| Closed | -$11.8M | – |
|
94
BellRing Brands
BRBR
$990M
| – | – |
-94,100
| Closed | -$1.51M | – |
|
95
BorgWarner
BWA
$12.3B
| – | – |
-43,000
| Closed | -$2.33M | – |
|
96
Definitive Healthcare
DH
$105M
| – | – |
-239,630
| Closed | -$295K | – |
|
97
Embecta
EMBC
$351M
| – | – |
-105,211
| Closed | -$930K | – |
|
98
Helen of Troy
HELE
$651M
| – | – |
-34,200
| Closed | -$493K | – |
|
99
Lantheus
LNTH
$6.53B
| – | – |
-42,000
| Closed | -$3.19M | – |
|
100
Northrop Grumman
NOC
$68.4B
| – | – |
-305
| Closed | -$208K | – |
|
Similar funds
BHWM
BRF
SCP
CCMI
DCM
HSA
NICM
SWA
Clark Estates Inc's Q2 2026 Portfolio in Review
As of Q2 2026, Clark Estates Inc held 108 positions worth $434M, up 4.2% from $416M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Clark Estates Inc's Q2 2026 filing shows 11 new, 17 increased, 16 reduced and 18 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M. The largest sale was Euclidean Fundamental Value ETF, an estimated $15M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Miscellaneous and Technology.
- Clark Estates Inc's largest Q2 2026 buy was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M.
- Clark Estates Inc added most to Henry Schein in Q2 2026, an estimated $9.71M increase.
- Clark Estates Inc's biggest Q2 2026 reduction was Euclidean Fundamental Value ETF, cutting an estimated $15M.
- Clark Estates Inc fully exited Avanos Medical in Q2 2026, selling an estimated $11.8M.
- Clark Estates Inc's ten largest holdings make up 53% of its $434M portfolio in Q2 2026.
- Clark Estates Inc opened 11 new positions and closed 18 in Q2 2026.
- Clark Estates Inc's portfolio value rose 4.2% quarter-over-quarter to $434M.
Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.